Daily Journal Staff Writer
Brisbane-based drug developer InterMune Inc. tapped a New York-based team of attorneys at Cravath, Swaine & Moore LLP to handle its $8.3 billion sale to Swiss pharmaceutical giant Roche Holding AG.
The all-cash deal, announced Sunday, would help Roche bolster its portfolio of respiratory drugs, the company said in a statement.
Partners Faiza J. Saeed and Ting S. Chen led Cravath...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In